US20080308444A1 - Packaging system and method of alerting a practitioner - Google Patents
Packaging system and method of alerting a practitioner Download PDFInfo
- Publication number
- US20080308444A1 US20080308444A1 US11/762,494 US76249407A US2008308444A1 US 20080308444 A1 US20080308444 A1 US 20080308444A1 US 76249407 A US76249407 A US 76249407A US 2008308444 A1 US2008308444 A1 US 2008308444A1
- Authority
- US
- United States
- Prior art keywords
- label
- container
- packaging system
- open end
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/18—Arrangements for indicating condition of container contents, e.g. sterile condition
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D23/00—Details of bottles or jars not otherwise provided for
- B65D23/08—Coverings or external coatings
- B65D23/0842—Sheets or tubes applied around the bottle with or without subsequent folding operations
- B65D23/085—Sheets or tubes applied around the bottle with or without subsequent folding operations and glued or otherwise sealed to the bottle
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/24—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes
- B65D51/245—Closures not otherwise provided for combined or co-operating with auxiliary devices for non-closing purposes provided with decoration, information or contents indicating devices, labels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D55/00—Accessories for container closures not otherwise provided for
- B65D55/02—Locking devices; Means for discouraging or indicating unauthorised opening or removal of closure
- B65D55/06—Deformable or tearable wires, strings, or strips; Use of seals, e.g. destructible locking pins
- B65D55/08—Annular elements encircling container necks
- B65D55/0818—Destructible or permanently removable bands, e.g. adhesive
Definitions
- This patent is directed to a packaging system and methods of use, and, in particular, to a packaging system with informational features and methods of use.
- One common way of administering pharmaceutical products is by injecting the product in liquid form.
- the liquid product will be packaged in a vial in a condition ready for administration.
- the vial will have a stopper at one end, through which a needle of a syringe may be passed so as to draw the product out of the vial.
- a label is affixed to the outside of the vial so that a medical professional can determine the contents of the vial.
- a textual description of the product will be oriented about the periphery of the vial, or aligned with the axis of the vial. Sometimes, a portion or region of the label will be color-coded to differentiate different products and/or dosages for the professional that will be administering the product.
- a packaging system in one aspect, includes a container having a closed end, an open end, a longitudinal axis running through the closed end and the open end, and an outer surface, a closure assembly fitted to the open end of the container and having an access port, and a detachable cap disposed over the access port.
- the system also includes a label disposed about the container, the label having a first region angled relative to the longitudinal axis, the first region consisting essentially of a name of a product.
- a method of alerting a practitioner to contents of a container includes providing a container having a closed end, an open end, a longitudinal axis running through the closed end and the open end, and an outer surface, and disposing a label about the container, the label having a first region angled relative to the longitudinal axis, the first region consisting essentially of a name of a product.
- FIG. 1 is a perspective view of the packaging system according to the present disclosure with a two-part label, the label being intact;
- FIG. 2 is a perspective view of the packaging system of FIG. 1 with the sections of the label separated and the cap removed;
- FIG. 3 is a flowchart illustrating the method of use of the packaging system of FIG. 1 ;
- FIG. 4 is a cross-sectional view of the packaging system with the label intact as in FIG. 1 ;
- FIG. 5 is a perspective view of the packaging system illustrating the angle, taken relative to the longitudinal axis, of the first and second regions of the first section of the label;
- FIG. 6 is a perspective view of an alternative embodiment of the packaging system according to the present disclosure with a one-part label.
- FIG. 7 is a plan view of an alternative embodiment of a cap for use with the packaging system of FIG. 1 .
- FIGS. 1-5 illustrate an embodiment of packaging system 50 according to the present disclosure and its use.
- Packaging system 50 may be used for a pharmaceutical product, such as heparin or morphine.
- packaging system 50 may be used with other products.
- injectable drugs employed in system 50 may include, but are not limited to: abarelix, abciximab, acetazolamide, acetonide, acetylcysteine, acyclovir, adalimumab, adenosine, adipiodone, agalsidase beta, albumin, aldesleukin, aldesleukin, alefacept, alemtuzumab, alfentanil, alglucosidase, allopurinol, alpha 1-proteinase inhibitor, alphacon-1, alprostadil, alteplase, amifostine, amikacin, aminocaproic acid, aminophylline, amiodarone, amobar
- packaging system 50 includes container 60 , closure assembly 70 , cap 80 , and label 90 .
- Closure assembly 70 is fitted to an open end of container 60 , and includes an access port. Closure assembly 70 may be resealable.
- Cap 80 is fitted over the access port, and label 90 is disposed about container 60 .
- Label 90 has first and second sections 92 , 94 , separated by perforated boundary 96 .
- First section 92 of label 90 is attached at least in part to an outer surface of container 60 .
- Label 90 may partially or fully cover the perimeter of container 60 .
- First section 92 of label 90 covers container 60 up to perforated boundary 96 .
- Second section 94 extends at least between perforated boundary 96 and cap 80 .
- First section 92 of label 90 has first region 100 and, optionally, second region 102 .
- First and second regions 100 , 102 extend from perforated boundary 96 to the opposing edge of first section 92 .
- First and second regions 100 , 102 are angled relative to longitudinal axis 104 of system 50 (see FIG. 5 ).
- First region 100 consists essentially of the name of a product to be packaged in container 60 .
- Optional second region 102 consists essentially of a concentration of the product, or other description of the product.
- Second section 94 of label 90 may include informational or warning message 110 .
- FIG. 3 A method of use of packaging system 50 is illustrated in FIG. 3 .
- a user grasps container 60 (block 112 ).
- the user then breaks label 90 along perforated boundary 96 , thereby separating first section 92 of label 90 from second section 94 (block 114 ).
- Boundary 96 may be broken by grasping an edge of second section 94 , preferably normal to the axis 104 , and tearing second section 94 loose from first section 92 and cap 80 . This motion also may result in removal of the section 94 (block 116 ).
- cap 80 may be removed from container 60 ( 118 ).
- the removal of section 92 and cap 80 may be achieved in a single step.
- Packaging system 50 in general, and label 90 in particular, includes a number of informational features that assist the user administering the product packaged in container 60 .
- label 90 has been designed to highlight the name and, optionally, the concentration of the product, or other description of the product.
- One way in which the name and concentration have been highlighted is through the unconventional orientation of regions 100 , 102 of label 90 , which regions 100 , 102 are neither parallel nor orthogonal to axis 104 .
- label 90 reduces the informational “clutter” that may accompany conventional presentations.
- System 50 also requires active manipulation of label 90 during the use of system 50 , namely the separation of label 90 along perforated boundary 96 . It is believed that active manipulation of label 90 will improve the user's appreciation of the informational content of label 90 .
- Each of these features may contribute to the improvements provided by system 50 .
- FIG. 4 The embodiment of system 50 illustrated in general terms in FIGS. 1 and 2 is now described in greater detail with regard to FIG. 4 .
- container 60 may be in the form of a vial.
- Vial 60 may be cylindrical in shape, and may be made of a materials such as glass or plastic, for example.
- the vial may have wall 120 that defines first, closed end 122 and second, open end 124 .
- Wall 120 may have outer surface 126 and inner surface 128 , which in turn defines receptacle 130 .
- Wall 120 may also define flange-like rim 132 that is disposed about open end 124 .
- rim 132 may have an annular shape, with outermost edge 134 and opposing surfaces 136 , 138 .
- system 50 has longitudinal axis 104 .
- closed end 122 and open end 124 of vial 60 may have a substantially circular shape, with centerpoints, one of which ( 142 ) is shown.
- longitudinal axis 104 may pass through centerpoints 142 of closed and open ends 122 , 124 .
- closure assembly 70 Fitted to open end 124 of vial 60 is closure assembly 70 .
- closure assembly 70 may include valve 150 and crimp ring 152 .
- Valve 150 controls access to open end 124 of vial 60
- crimp ring 152 maintains the position of valve 150 at open end 124 .
- Valve 150 may be defined by a layer of Teflon-coated rubber, the layer having opposing first and second surfaces 162 , 164 and outer edge 166 . Given the cylindrical geometry of vial 60 , outer edge 166 of valve 150 may be circular in shape. Given the material used, the layer may be punctured repeatedly by a needle, for example, but reseal thereafter so as to limit movement of product disposed in receptacle 130 through open end 124 .
- Crimp ring 152 may be defined by cylindrical metal sleeve 170 having a cylindrical shape.
- Sleeve 170 has first end 172 with annular metal band 174 that defines circular opening 176 .
- Sleeve 170 also has intermediate, tube-like portion 178 and second end 180 .
- valve 150 is disposed with second surface 164 disposed over open end 124 of vial 60 abutting surface 136 .
- Edge 166 of valve 150 may, but need not necessarily, extend to outermost edge 134 of rim 132 .
- Crimp ring 152 may be disposed over the assembly of valve 150 and vial 60 , such that first end 172 abuts first surface 162 of valve 150 . Opening 176 thereby defines access port 182 for closure assembly 70 .
- second end 180 is disposed over and about rim 132 such that second end 180 abuts surface 138 .
- Cap 80 Disposed over access port 182 is cap 80 .
- Cap 80 may be made of a plastic or metal material.
- Cap 80 may have opposing surfaces 190 , 192 and downturned edge 194 .
- Cap 80 is disposed over crimp ring 152 such that surface 192 abuts first end 172 of ring 152 .
- cap 80 may be attached to closure assembly 70 , and in particular the portion of closure assembly 70 that defines access port 182 , with a releasable adhesive or by friction fitting, for example.
- label 90 may be made of paper or other material suitable for printing that has been backed, at least in part, with an adhesive.
- the adhesive used with label 90 may require label 90 to be torn to remove label 90 from the surface to which it is affixed.
- First section 92 of label 90 may be attached at least in part to outer surface 126 of vial 60 .
- Second section 94 of label 90 may be attached at least in part to cap 80 , and in particular edge 194 .
- First section 92 may extend from first edge 200 generally aligned with closed end 122 of vial 60 to perforated boundary 96 .
- First region 100 of first section 92 may thus extend substantially from closed end 122 of vial 60 to perforated boundary 96 .
- second region 102 of first section 92 may also substantially extend from closed end 122 to perforated boundary 96 .
- First and second regions 100 , 102 may, as noted above, be angled relative to longitudinal axis 104 .
- the nature of this relationship is shown particularly in FIG. 5 .
- to be angled relative to the longitudinal axis means that regions 100 , 102 are not aligned with axis 104 (parallel to axis 104 ), nor do regions 100 , 102 lie in a plane that is orthogonal or substantially orthogonal to longitudinal axis 104 . Rather, regions 100 , 102 lie in planes that make non-zero, non-right angle ⁇ with longitudinal axis 104 .
- the text in remainder 202 of first section 92 may be aligned either along axis 104 or orthogonal or substantially orthogonal to axis 104 .
- the angle of regions 100 , 102 relative to axis 104 may lie in the range of between twenty and eighty degrees, and more preferably in the range of between thirty degrees and sixty degrees. As illustrated, the angle may be forty-five degrees. Shallower and steeper angles may be possible in certain embodiments.
- the angle of regions 100 , 102 it is presently believed that the angle should not be selected so shallow as to extend region 100 , 102 more than half-way about the periphery of container 60 . That is, if region 100 , 102 extends through more than about 180 degrees about the periphery of container 60 , the user may not be able to visualize all of the information contained in region 100 , 102 at a single time. To maximize the possibility that all of the information in a given region 100 , 102 may be read by the user at one time, the angle of inclination of region 100 , 102 may thus be limited.
- First and second regions 100 , 102 may have a contrasting background color in regard to remainder 202 of first section 92 of label 90 . That is, if remainder 202 of label 90 has a tan background color, for example, regions 100 , 102 may have a neutral color or white for the background color. A contrasting background color may further differentiate regions 100 , 102 in combination with the angled nature of regions 100 , 102 .
- regions 100 , 102 may be provided through the use of a contrasting font type or font size.
- the text in remainder 202 of first section 92 of the label may have a six point font size
- the text in regions 100 , 102 may have a ten point font size.
- regions 100 , 102 may include more area than a region oriented parallel to or orthogonal to axis 104 , thus permitting use of a larger font size.
- the contrasting background font may further differentiate regions 100 , 102 . Any font size may be printed on regions 100 , 102 and sections 92 , 94 , so long as such sizes identify the product, other descriptions and warnings to the user of the product.
- angled regions 100 , 102 with contrasting color and font size
- angled regions 100 , 102 may be used in combination with neither, either or both of the contrasting color and the contrasting font size.
- Second section 94 may extend from perforated boundary 96 to second edge 210 .
- Second edge 210 may be disposed above edge 194 of cap 80 .
- second edge 210 may be generally aligned with first surface 190 of cap 80 .
- Second section 94 may have a contrasting background color relative to first section 92 of label 90 .
- first section 92 may feature background colors of tan and white
- second section 94 may feature a background color such as red.
- colors such as red, orange and fluorescent yellow may be used for the background color of second section 94 .
- Any color combination may be employed in sections 92 , 94 , but preferably such section colors contrast to aid the practitioner in using system 50 . As noted above, it is not necessary for all embodiments of present system 50 to use such colors, although it may aid in differentiating warning message 110 displayed in second section 94 from other portions of label 90 .
- Warning message 110 may be textual, in the form of alphanumeric characters, for example. However, warning message 110 is not limited to alphanumeric characters. For example, icons or symbols may be used in combination with or in substitution for alphanumeric message 110 . For that matter, message 110 may be conveyed without any icons, symbols, or characters at all, but by the color of section 94 alone. If a textual message is incorporated into warning message 110 , then the font size of the text may be varied relative to that used in one or more regions 100 , 102 , 202 of first section 92 of label 90 to create differentiation.
- second section 92 of label 90 may be optional, and may not be included according to all embodiments of system 50 according to the present disclosure.
- An illustration of such an embodiment is illustrated in FIG. 6 , with similar parts numbered similarly.
- Label 220 is disposed about vial 60 .
- Label 220 has a single section with first region 222 and, optionally, second region 224 .
- the remainder of label 220 is indicated as 226 .
- Regions 222 , 224 lie in planes that make a non-zero, non-right angle with a longitudinal axis of the vial 60 , similar to regions 100 , 102 .
- the comments made relative regions 100 , 102 and remainder 202 may apply with equal force to regions 222 , 224 and reminder 226 .
- a label with angled regions may be used with containers other than a vial, as shown; the label may be used with ampuls, syringes, and other devices.
- the perforated boundary may be used in a label without the angled regions in the first section of the label.
- crimp ring 152 may have a color that contrasts with one or more of regions 100 , 102 , 202 of first section 92 of label 90 .
- color of crimp ring 152 may preferably be red, orange or fluorescent yellow, similar to the color of second section 94 of label 90 .
- crimp ring 152 may have a warning message displayed on a portion or area of ring 152 .
- ring 152 may have a warning message defined or displayed on intermediate region 178 between first and second ends 172 , 180 .
- the warning message may be defined or displayed on band 174 disposed about opening 176 that defines, in part, access port 182 . Similar comments to those made above relative to warning message 110 may be made in regard to the warning message displayed on crimp ring 152 .
- warning message 240 may be displayed or defined on a portion or area of cap 80 .
- the message may be displayed or defined on surface 190 of cap 80 .
- message 240 may be disposed about the periphery of surface 190 of cap 80 .
Abstract
Description
- This patent is directed to a packaging system and methods of use, and, in particular, to a packaging system with informational features and methods of use.
- One common way of administering pharmaceutical products is by injecting the product in liquid form. Often, the liquid product will be packaged in a vial in a condition ready for administration. The vial will have a stopper at one end, through which a needle of a syringe may be passed so as to draw the product out of the vial.
- A label is affixed to the outside of the vial so that a medical professional can determine the contents of the vial. A textual description of the product will be oriented about the periphery of the vial, or aligned with the axis of the vial. Sometimes, a portion or region of the label will be color-coded to differentiate different products and/or dosages for the professional that will be administering the product.
- It is important that the label accurately convey the identification of the product and dosage to the administering professional. Certain pharmaceuticals (e.g., morphine) are so powerful that administration of the pharmaceutical except where indicated is to be avoided whenever possible. Other pharmaceutical products may contain the same active agent, but at different concentrations and, therefore, are intended for completely different purposes (compare Heparin and Hep-Lock products). In either instance, administration of a product where not indicated (or contraindicated) may have severe consequences, and may even lead to the death of the patient.
- In one aspect, a packaging system includes a container having a closed end, an open end, a longitudinal axis running through the closed end and the open end, and an outer surface, a closure assembly fitted to the open end of the container and having an access port, and a detachable cap disposed over the access port. The system also includes a label disposed about the container, the label having a first region angled relative to the longitudinal axis, the first region consisting essentially of a name of a product.
- In another aspect, a method of alerting a practitioner to contents of a container is provided. The method includes providing a container having a closed end, an open end, a longitudinal axis running through the closed end and the open end, and an outer surface, and disposing a label about the container, the label having a first region angled relative to the longitudinal axis, the first region consisting essentially of a name of a product.
- Additional aspects of the disclosure are defined by the claims of this patent.
-
FIG. 1 is a perspective view of the packaging system according to the present disclosure with a two-part label, the label being intact; -
FIG. 2 is a perspective view of the packaging system ofFIG. 1 with the sections of the label separated and the cap removed; -
FIG. 3 is a flowchart illustrating the method of use of the packaging system ofFIG. 1 ; -
FIG. 4 is a cross-sectional view of the packaging system with the label intact as inFIG. 1 ; -
FIG. 5 is a perspective view of the packaging system illustrating the angle, taken relative to the longitudinal axis, of the first and second regions of the first section of the label; -
FIG. 6 is a perspective view of an alternative embodiment of the packaging system according to the present disclosure with a one-part label; and -
FIG. 7 is a plan view of an alternative embodiment of a cap for use with the packaging system ofFIG. 1 . - Although the following text sets forth a detailed description of different embodiments of the invention, it should be understood that the legal scope of the invention is defined by the words of the claims set forth at the end of this patent. The detailed description is to be construed as exemplary only and does not describe every possible embodiment of the invention since describing every possible embodiment would be impractical, if not impossible. Numerous alternative embodiments could be implemented, using either current technology or technology developed after the filing date of this patent, which would still fall within the scope of the claims defining the invention.
- It should also be understood that, unless a term is expressly defined in this patent using the sentence “As used herein, the term ‘______’ is hereby defined to mean . . . ” or a similar sentence, there is no intent to limit the meaning of that term, either expressly or by implication, beyond its plain or ordinary meaning, and such term should not be interpreted to be limited in scope based on any statement made in any section of this patent (other than the language of the claims). To the extent that any term recited in the claims at the end of this patent is referred to in this patent in a manner consistent with a single meaning, that is done for sake of clarity only so as to not confuse the reader, and it is not intended that such claim term be limited, by implication or otherwise, to that single meaning. Finally, unless a claim element is defined by reciting the word “means” and a function without the recital of any structure, it is not intended that the scope of any claim element be interpreted based on the application of 35 U.S.C. §112, sixth paragraph.
-
FIGS. 1-5 illustrate an embodiment ofpackaging system 50 according to the present disclosure and its use.Packaging system 50 may be used for a pharmaceutical product, such as heparin or morphine. Alternatively,packaging system 50 may be used with other products. Examples of injectable drugs employed insystem 50 may include, but are not limited to: abarelix, abciximab, acetazolamide, acetonide, acetylcysteine, acyclovir, adalimumab, adenosine, adipiodone, agalsidase beta, albumin, aldesleukin, aldesleukin, alefacept, alemtuzumab, alfentanil, alglucosidase, allopurinol, alpha 1-proteinase inhibitor, alphacon-1, alprostadil, alteplase, amifostine, amikacin, aminocaproic acid, aminophylline, amiodarone, amobarbital, amphotericin b, ampicillin, amrinone, anakinra, antithrombin iii, antivenom serum, apomorphine, aprotinin, aredia, argatroban, arginine, aripiprazole, asparaginase, atenolol, atracurium, atropine, aurothioglucose, axetil, azacitidine, azathioprine, azithromycin, aztreonam, bacillus calmette-guerin, bacitracin, basiliximab, benzoic acid, benztropine, betamethasone, bevacizumab, bivalirudin, bleomycin, bortezomib, botulinum a toxin, bretylium, bumetanide, bupivacaine, buprenorphine, busulfan, butorphanol, caffeine, calcitonin (salmon), calcitriol, capreomycin, carboplatin, carboprost, carmine, carmustine, carnitine, caspofungin, cefazolin, cefepime, cefotaxime, cefotetan, cefoxitin, ceftazidime, ceftizoxime, ceftriaxone, cefuroxime, cefuroxime, cetuximab, chloramphenicol, chloroprocaine, chlorothiazide, chlorpromazine, chondroitin, choriogonadotropin alfa, cidofovir, cilastatin, cimetidine, cinacalcet, ciprofloxacin, cisatracurium, cisplatin, cladribine, clavulanic acid, clindamycin, clofarabine, clonidine, codeine, colchicine, colistin, conivaptan, corticorelin, corticotrophin, cosyntropin, cyanocobalamin, cyclophosphamide, cyclosporine, cysteine, cytarabine, dacarbazine, daclizumab, dactinomycin, dalfopristin, dalteparin, dantrolene, daptomycin, darbepoetin alfa, daunorubicin, ddavp, decitabine, deferoxamine, denileukin diftitox, desmopressin, dexamethasone, dexmedetomidine, dexpanthenol, dexrazoxane, dextasone, diatrizoic acid, diazepam, diazoxide, dicyclomine, digibind, digoxin, dihydroergotamine, diltiazem, dimenhydrinate, diphenhydramine, dipyridamole, dobutamine, docetaxel, dolasetron, dopamine, dornase alfa, doxacurium, doxapram, doxercalciferol, doxorubicin, doxycycline, droperidol, drotrecogin alfa, dyphylline, eculizumab, edetic acid, edrophonium, efalizumab, enalaprilat, enoxaparin, ephedrine, epinephrine, epirubicin, epoetin alpha, epoprostenol, eptacog alfa, eptifibatide, ergocalciferol, ergocalciferol, ertapenem, erythromycin, erythropoietin alpha, esmolol, esomeprazole, estradiol, estrogen, etanercept, ethacrynic acid, ethanolamine, ethiodized oil, etidronic acid, etomidate, etoposide, exenatide, factor ii, factor ix, factor vii, factor viii, factor x, famotidine, fenoldopam, fentanyl, filgrastim, floxuridine, fluconazole, fludarabine, flumazenil, fluorescein, fluphenazine, follicle-stimulating hormone, follitropin, fomepizole, fondaparinux, foscarnet, fosphenytoin, fulvestrant, furosemide, gadobenic acid, gadodiamide, gadopentetate, gadoteridol, gadoversetamide, gallium, galsulfase, ganciclovir, ganirelex, gatifloxacin, gemcitabine, gemtuzumab, gentamicin, glatiramer, glucagon, glycopyrrolate, gm-csf, gold sodium thiomalate, gonadorelin, gonadotropin, goserelin, granisetron, haemophilus b polysaccaride, haloperidol, hemin, heparin, hetastarch, hexacetonide, histamine, hyaluronic acid, hyaluronidase, hydralazine, hydrocortisone, hydromorphone, hydroxocobalamin, hydroxyzine, hylan, hyoscyamine, hypromellose, ibuprofen, ibutilide, idarubicin, idursulfase, ifosfamide, imatinib mesylate, imiglucerase, imipenem, immune globulin, indigo, indomethacin, infliximab, insulin, interferons, iodine, iodixanol, iohexol, iopamidol, iopromide, iothalamic acid, ioversol, ioxaglic acid, ioxilan, irinotecan, iron dextran, isoniazid, isophane, isoproterenol, kanamycin, ketamine, ketorolac, labetalol, lansoprazole, laronidase, lepirudin, leucovorin, leuprolide, levetiracetam, levobupivacaine, levofloxacin, levothyroxine, lidocaine, lincomycin, linezolid, liothyronine, lispro, lorazepam, luteinising hormone, mechlorethamine, medroxyprogesterone, melphalan, meperidine, meperidine, mepivacaine, meropenem, mesna, metaraminol, methadone, methocarbamol, methohexital, methotrexate, methoxamine, methyldopate, methylene blue, methylergonovine, methylprednisolone, metoclopramide, metoprolol, metronidazole, micafungin, midazolam, milrinone, minocycline, mitomycin, mitoxantrone, mivacurium, mofetil, molybdenum, morphine, morrhuic acid, moxifloxacin, muromonab-cd3, mycophenolate, nafcillin, nalbuphine, nalmefene, naloxone, nandrolone, natalizumab, nelarabine, neostigmine, nesiritide, nicardipine, nitroglycerin, nitroprusside, norepinephrine, octreotide, olanzapine, omalizumab, ondansetron, oprelvekin, orphenadrine, ovine, oxacillin, oxaliplatin, oxymorphone, oxytetracycline, oxytocin, ozogamicin, paclitaxel, palifermin, palivizumab, palonosetron, pamidronic acid, pancuronium, panitumumab, pantoprazole, papaverine, paricalcitol, pegalated interferon alfa-2b, pegaptanib, pegaspargase, pegfilgrastim, pegvisomant, pegylated liposomal doxorubicin, pemetrexed, penicillin g, pentamidine, pentazocine, pentobarbital, pentostatin, phenobarbital, phentolamine, phenylacetic acid, phenylephrine, phenytoin, physostigmine, phytonadione, piperacillin, polymyxin b, porfimer, pralidoxime, pramlintide, prilocaine, procainamide, procaine, prochlorperazine, progesterone, promethazine, propofol, propranolol, protamine, pyridostigmine hydroxide, pyridoxine, quinidine, quinupristin, ranitidine, rasburicase, remifentanil, rho d immune globulin, rifampin, rituximab, rocuronium, ropivacaine, scopolamine, secretin, sermorelin, sincalide, somatrem, somatropin, spectinomycin, streptokinase, streptomycin, streptozocin, succinylcholine, sufentanil, sulbactam, sulfamethoxazole, sulphan blue, sumatriptan, tacrolimus, tazobactam, teniposide, terbutaline, teriparatide, testosterone, tetracaine, tetradecyl sulfate, theophylline, thiamine, thiopental, thiotepa, thyroid stimulating hormone, thyrotropin, ticarcillin, tigecycline, tinzaparin, tirofiban, tobramycin, topotecan, torsemide, tranexamic acid, trastuzumab, treprostinil, triamcinolone, triflutate, trimethobenzamide, trimethoprim, trimetrexate, triptorelin, tromethamine, tuberculin, typhoid vaccine, urofollitropin, urokinase, valproic acid, vancomycin, varicella, vasopressin, vecuronium, verapamil, verteporfin, vinblastine, vincristine, vinorelbine, voriconazole, warfarin, ziconotide, zidovudine, ziprasidone, and zoledronic acid.System 50, in its various embodiments, may also be useful for the provision of vaccines, vitamins and other nutritional agents. - Referring to
FIGS. 1 and 2 ,packaging system 50 includescontainer 60,closure assembly 70,cap 80, andlabel 90. Closureassembly 70 is fitted to an open end ofcontainer 60, and includes an access port.Closure assembly 70 may be resealable.Cap 80 is fitted over the access port, andlabel 90 is disposed aboutcontainer 60. -
Label 90 has first andsecond sections perforated boundary 96.First section 92 oflabel 90 is attached at least in part to an outer surface ofcontainer 60.Label 90 may partially or fully cover the perimeter ofcontainer 60.First section 92 oflabel 90 coverscontainer 60 up to perforatedboundary 96.Second section 94 extends at least betweenperforated boundary 96 andcap 80. -
First section 92 oflabel 90 hasfirst region 100 and, optionally,second region 102. First andsecond regions perforated boundary 96 to the opposing edge offirst section 92. First andsecond regions longitudinal axis 104 of system 50 (seeFIG. 5 ).First region 100 consists essentially of the name of a product to be packaged incontainer 60. Optionalsecond region 102 consists essentially of a concentration of the product, or other description of the product.Second section 94 oflabel 90 may include informational orwarning message 110. - A method of use of
packaging system 50 is illustrated inFIG. 3 . First, a user grasps container 60 (block 112). The user then breakslabel 90 alongperforated boundary 96, thereby separatingfirst section 92 oflabel 90 from second section 94 (block 114).Boundary 96 may be broken by grasping an edge ofsecond section 94, preferably normal to theaxis 104, and tearingsecond section 94 loose fromfirst section 92 andcap 80. This motion also may result in removal of the section 94 (block 116). Finally,cap 80 may be removed from container 60 (118). Optionally, though not preferred, it is possible to removecap 80 first, followed by the breaking ofboundary 96. Also, the removal ofsection 92 andcap 80 may be achieved in a single step. -
Packaging system 50 in general, andlabel 90 in particular, includes a number of informational features that assist the user administering the product packaged incontainer 60. For instance,label 90 has been designed to highlight the name and, optionally, the concentration of the product, or other description of the product. One way in which the name and concentration have been highlighted is through the unconventional orientation ofregions label 90, whichregions axis 104. Further, by segregating essentially only the name and concentration toregions label 90 reduces the informational “clutter” that may accompany conventional presentations.System 50 also requires active manipulation oflabel 90 during the use ofsystem 50, namely the separation oflabel 90 alongperforated boundary 96. It is believed that active manipulation oflabel 90 will improve the user's appreciation of the informational content oflabel 90. Each of these features may contribute to the improvements provided bysystem 50. - The embodiment of
system 50 illustrated in general terms inFIGS. 1 and 2 is now described in greater detail with regard toFIG. 4 . - According to the present embodiment of
system 50,container 60 may be in the form of a vial.Vial 60 may be cylindrical in shape, and may be made of a materials such as glass or plastic, for example. The vial may havewall 120 that defines first,closed end 122 and second,open end 124.Wall 120 may haveouter surface 126 andinner surface 128, which in turn definesreceptacle 130.Wall 120 may also define flange-like rim 132 that is disposed aboutopen end 124. Given the cylindrical shaped ofvial 60,rim 132 may have an annular shape, withoutermost edge 134 and opposingsurfaces - As mentioned previously,
system 50 haslongitudinal axis 104. As illustrated best inFIGS. 1 and 5 ,closed end 122 andopen end 124 ofvial 60 may have a substantially circular shape, with centerpoints, one of which (142) is shown. According to at least the illustrated embodiment ofvial 60,longitudinal axis 104 may pass throughcenterpoints 142 of closed andopen ends - Fitted to open
end 124 ofvial 60 isclosure assembly 70. According to the illustrated embodiment,closure assembly 70 may includevalve 150 andcrimp ring 152.Valve 150 controls access toopen end 124 ofvial 60, whilecrimp ring 152 maintains the position ofvalve 150 atopen end 124. -
Valve 150 may be defined by a layer of Teflon-coated rubber, the layer having opposing first andsecond surfaces outer edge 166. Given the cylindrical geometry ofvial 60,outer edge 166 ofvalve 150 may be circular in shape. Given the material used, the layer may be punctured repeatedly by a needle, for example, but reseal thereafter so as to limit movement of product disposed inreceptacle 130 throughopen end 124. -
Crimp ring 152 may be defined bycylindrical metal sleeve 170 having a cylindrical shape.Sleeve 170 has first end 172 with annular metal band 174 that definescircular opening 176.Sleeve 170 also has intermediate, tube-like portion 178 andsecond end 180. - As assembled,
valve 150 is disposed withsecond surface 164 disposed overopen end 124 ofvial 60 abuttingsurface 136.Edge 166 ofvalve 150 may, but need not necessarily, extend tooutermost edge 134 ofrim 132.Crimp ring 152 may be disposed over the assembly ofvalve 150 andvial 60, such that first end 172 abutsfirst surface 162 ofvalve 150. Opening 176 thereby definesaccess port 182 forclosure assembly 70. With first end 172 abuttingfirst surface 162,second end 180 is disposed over and aboutrim 132 such thatsecond end 180 abutssurface 138. - Disposed over
access port 182 iscap 80.Cap 80 may be made of a plastic or metal material.Cap 80 may have opposingsurfaces downturned edge 194.Cap 80 is disposed overcrimp ring 152 such thatsurface 192 abuts first end 172 ofring 152. Furthermore, cap 80 may be attached toclosure assembly 70, and in particular the portion ofclosure assembly 70 that definesaccess port 182, with a releasable adhesive or by friction fitting, for example. - Returning to label 90,
label 90 may be made of paper or other material suitable for printing that has been backed, at least in part, with an adhesive. The adhesive used withlabel 90 may requirelabel 90 to be torn to removelabel 90 from the surface to which it is affixed.First section 92 oflabel 90 may be attached at least in part toouter surface 126 ofvial 60.Second section 94 oflabel 90 may be attached at least in part to cap 80, and inparticular edge 194. -
First section 92 may extend fromfirst edge 200 generally aligned withclosed end 122 ofvial 60 toperforated boundary 96.First region 100 offirst section 92 may thus extend substantially fromclosed end 122 ofvial 60 toperforated boundary 96. Similarly,second region 102 offirst section 92 may also substantially extend fromclosed end 122 toperforated boundary 96. - First and
second regions longitudinal axis 104. The nature of this relationship is shown particularly inFIG. 5 . As will be noted, to be angled relative to the longitudinal axis means thatregions regions longitudinal axis 104. Rather,regions longitudinal axis 104. By contrast, the text inremainder 202 offirst section 92 may be aligned either alongaxis 104 or orthogonal or substantially orthogonal toaxis 104. - According to certain embodiments, the angle of
regions axis 104 may lie in the range of between twenty and eighty degrees, and more preferably in the range of between thirty degrees and sixty degrees. As illustrated, the angle may be forty-five degrees. Shallower and steeper angles may be possible in certain embodiments. - However, in selecting the angle of
regions region container 60. That is, ifregion container 60, the user may not be able to visualize all of the information contained inregion region region - First and
second regions remainder 202 offirst section 92 oflabel 90. That is, ifremainder 202 oflabel 90 has a tan background color, for example,regions regions regions - A still further differentiation of
regions regions remainder 202 offirst section 92 of the label may have a six point font size, the text inregions regions axis 104,regions axis 104, thus permitting use of a larger font size. Similar to the contrasting background color, the contrasting background font may further differentiateregions regions sections - It will be recognized that while the illustrated embodiment uses
angled regions angled regions -
Second section 94 may extend fromperforated boundary 96 tosecond edge 210.Second edge 210 may be disposed aboveedge 194 ofcap 80. According to certain embodiments, such as the embodiment illustrated,second edge 210 may be generally aligned withfirst surface 190 ofcap 80. -
Second section 94 may have a contrasting background color relative tofirst section 92 oflabel 90. In particular, whilefirst section 92 may feature background colors of tan and white, for example,second section 94 may feature a background color such as red. Preferably, colors such as red, orange and fluorescent yellow may be used for the background color ofsecond section 94. Any color combination may be employed insections system 50. As noted above, it is not necessary for all embodiments ofpresent system 50 to use such colors, although it may aid in differentiatingwarning message 110 displayed insecond section 94 from other portions oflabel 90. -
Warning message 110 may be textual, in the form of alphanumeric characters, for example. However, warningmessage 110 is not limited to alphanumeric characters. For example, icons or symbols may be used in combination with or in substitution foralphanumeric message 110. For that matter,message 110 may be conveyed without any icons, symbols, or characters at all, but by the color ofsection 94 alone. If a textual message is incorporated intowarning message 110, then the font size of the text may be varied relative to that used in one ormore regions first section 92 oflabel 90 to create differentiation. - It will be further recognized that a number of variants are possible, not only relative to the structures already discussed, but relative to additional features that may be combined with or substituted for those already described.
- For example,
second section 92 oflabel 90 may be optional, and may not be included according to all embodiments ofsystem 50 according to the present disclosure. An illustration of such an embodiment is illustrated inFIG. 6 , with similar parts numbered similarly.Label 220 is disposed aboutvial 60.Label 220 has a single section withfirst region 222 and, optionally,second region 224. The remainder oflabel 220 is indicated as 226.Regions vial 60, similar toregions label 220 has but a single section, the comments maderelative regions remainder 202 may apply with equal force toregions reminder 226. In fact, such a label with angled regions may be used with containers other than a vial, as shown; the label may be used with ampuls, syringes, and other devices. It will also be recognized that the perforated boundary may be used in a label without the angled regions in the first section of the label. - As another example of an alternative embodiment,
crimp ring 152 may have a color that contrasts with one or more ofregions first section 92 oflabel 90. In this regard, color ofcrimp ring 152 may preferably be red, orange or fluorescent yellow, similar to the color ofsecond section 94 oflabel 90. - Further,
crimp ring 152 may have a warning message displayed on a portion or area ofring 152. For example,ring 152 may have a warning message defined or displayed onintermediate region 178 between first and second ends 172, 180. Alternatively, the warning message may be defined or displayed on band 174 disposed about opening 176 that defines, in part,access port 182. Similar comments to those made above relative towarning message 110 may be made in regard to the warning message displayed oncrimp ring 152. - Additionally or in the alternative, warning
message 240 may be displayed or defined on a portion or area ofcap 80. For example, the message may be displayed or defined onsurface 190 ofcap 80. In particular, as illustrated inFIG. 7 ,message 240 may be disposed about the periphery ofsurface 190 ofcap 80.
Claims (14)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/762,494 US20080308444A1 (en) | 2007-06-13 | 2007-06-13 | Packaging system and method of alerting a practitioner |
MX2007014336A MX2007014336A (en) | 2007-06-13 | 2007-07-23 | Packaging system and method of alerting a practitioner. |
PCT/US2007/074117 WO2008153581A1 (en) | 2007-06-13 | 2007-07-23 | Packaging system and method of alerting a practitioner |
CA2602044A CA2602044C (en) | 2007-06-13 | 2007-07-23 | Packaging system and method of alerting a practitioner |
DE602007007591T DE602007007591D1 (en) | 2007-06-13 | 2007-09-24 | packaging system |
PT07253775T PT2003064E (en) | 2007-06-13 | 2007-09-24 | Packaging system |
AT07253775T ATE473175T1 (en) | 2007-06-13 | 2007-09-24 | PACKAGING SYSTEM |
PL07253775T PL2003064T3 (en) | 2007-06-13 | 2007-09-24 | Packaging system |
ES07253775T ES2348628T3 (en) | 2007-06-13 | 2007-09-24 | PACKING SYSTEM |
EP07253775A EP2003064B1 (en) | 2007-06-13 | 2007-09-24 | Packaging system |
JP2007270715A JP2008307361A (en) | 2007-06-13 | 2007-10-17 | Packaging system and method of alerting medical worker |
US12/871,101 US9463138B2 (en) | 2007-06-13 | 2010-08-30 | Packaging system |
US13/970,194 US20130334165A1 (en) | 2007-06-13 | 2013-08-19 | Packaging system and methods of alerting a practitioner |
US14/591,512 US10702452B2 (en) | 2007-06-13 | 2015-01-07 | Packaging system and methods of alerting a practitioner |
US16/752,033 US20200163833A1 (en) | 2007-06-13 | 2020-01-24 | Packaging System and Methods of Alerting a Practitioner |
US16/751,958 US20200163832A1 (en) | 2007-06-13 | 2020-01-24 | Packaging system and methods of alerting practitioner |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/762,494 US20080308444A1 (en) | 2007-06-13 | 2007-06-13 | Packaging system and method of alerting a practitioner |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/871,101 Continuation US9463138B2 (en) | 2007-06-13 | 2010-08-30 | Packaging system |
US13/970,194 Continuation US20130334165A1 (en) | 2007-06-13 | 2013-08-19 | Packaging system and methods of alerting a practitioner |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080308444A1 true US20080308444A1 (en) | 2008-12-18 |
Family
ID=39031574
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/762,494 Abandoned US20080308444A1 (en) | 2007-06-13 | 2007-06-13 | Packaging system and method of alerting a practitioner |
US12/871,101 Active 2029-10-24 US9463138B2 (en) | 2007-06-13 | 2010-08-30 | Packaging system |
US13/970,194 Abandoned US20130334165A1 (en) | 2007-06-13 | 2013-08-19 | Packaging system and methods of alerting a practitioner |
US14/591,512 Active 2028-10-30 US10702452B2 (en) | 2007-06-13 | 2015-01-07 | Packaging system and methods of alerting a practitioner |
US16/751,958 Abandoned US20200163832A1 (en) | 2007-06-13 | 2020-01-24 | Packaging system and methods of alerting practitioner |
US16/752,033 Abandoned US20200163833A1 (en) | 2007-06-13 | 2020-01-24 | Packaging System and Methods of Alerting a Practitioner |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/871,101 Active 2029-10-24 US9463138B2 (en) | 2007-06-13 | 2010-08-30 | Packaging system |
US13/970,194 Abandoned US20130334165A1 (en) | 2007-06-13 | 2013-08-19 | Packaging system and methods of alerting a practitioner |
US14/591,512 Active 2028-10-30 US10702452B2 (en) | 2007-06-13 | 2015-01-07 | Packaging system and methods of alerting a practitioner |
US16/751,958 Abandoned US20200163832A1 (en) | 2007-06-13 | 2020-01-24 | Packaging system and methods of alerting practitioner |
US16/752,033 Abandoned US20200163833A1 (en) | 2007-06-13 | 2020-01-24 | Packaging System and Methods of Alerting a Practitioner |
Country Status (10)
Country | Link |
---|---|
US (6) | US20080308444A1 (en) |
EP (1) | EP2003064B1 (en) |
JP (1) | JP2008307361A (en) |
AT (1) | ATE473175T1 (en) |
DE (1) | DE602007007591D1 (en) |
ES (1) | ES2348628T3 (en) |
MX (1) | MX2007014336A (en) |
PL (1) | PL2003064T3 (en) |
PT (1) | PT2003064E (en) |
WO (1) | WO2008153581A1 (en) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080308443A1 (en) * | 2007-06-13 | 2008-12-18 | Baxter International Inc. | Packaging system and method of use |
US20100326868A1 (en) * | 2007-06-13 | 2010-12-30 | Baxter International Inc. | Packaging System |
US20130202823A1 (en) * | 2011-10-25 | 2013-08-08 | Wendell P. Weeks | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US20150166255A1 (en) * | 2013-12-12 | 2015-06-18 | ASCLEMED USA, INC. dba EnovaChem Manufacturing | Vitamin b-12 injection kit |
US9428302B2 (en) | 2012-06-28 | 2016-08-30 | Corning Incorporated | Delamination resistant glass containers with heat-tolerant coatings |
US9603775B2 (en) | 2013-04-24 | 2017-03-28 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9700485B2 (en) | 2013-04-24 | 2017-07-11 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9700486B2 (en) | 2013-04-24 | 2017-07-11 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9707155B2 (en) | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9707153B2 (en) | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9707154B2 (en) | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9713572B2 (en) | 2013-04-24 | 2017-07-25 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9717649B2 (en) | 2013-04-24 | 2017-08-01 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9717648B2 (en) | 2013-04-24 | 2017-08-01 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9839579B2 (en) | 2013-04-24 | 2017-12-12 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9849066B2 (en) | 2013-04-24 | 2017-12-26 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9988174B2 (en) | 2012-06-07 | 2018-06-05 | Corning Incorporated | Delamination resistant glass containers |
US10023495B2 (en) | 2012-11-30 | 2018-07-17 | Corning Incorporated | Glass containers with improved strength and improved damage tolerance |
US10065884B2 (en) | 2014-11-26 | 2018-09-04 | Corning Incorporated | Methods for producing strengthened and durable glass containers |
US10117806B2 (en) | 2012-11-30 | 2018-11-06 | Corning Incorporated | Strengthened glass containers resistant to delamination and damage |
US10350139B2 (en) | 2011-10-25 | 2019-07-16 | Corning Incorporated | Pharmaceutical glass packaging assuring pharmaceutical sterility |
US10899659B2 (en) | 2014-09-05 | 2021-01-26 | Corning Incorporated | Glass articles and methods for improving the reliability of glass articles |
EP4085891A1 (en) * | 2021-05-05 | 2022-11-09 | B. Braun Melsungen AG | Dexmedetomidine-solution in a low-density polyethylene container |
US11951072B2 (en) | 2019-10-15 | 2024-04-09 | Corning Incorporated | Glass containers with improved strength and improved damage tolerance |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010034583A1 (en) * | 2008-09-24 | 2010-04-01 | British American Tobacco (Investments) Limited | Label and container |
US20130096170A1 (en) | 2011-10-14 | 2013-04-18 | Hospira, Inc. | Methods of treating pediatric patients using dexmedetomidine |
US8242158B1 (en) | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
CA2872759C (en) | 2012-05-09 | 2020-04-21 | Schreiner Group Gmbh & Co. Kg | Closure element for a receptacle |
DE102012104062A1 (en) * | 2012-05-09 | 2013-11-14 | Schreiner Group Gmbh & Co. Kg | Closure element for vessel filled with pharmaceutical content, has tear strip that is arranged so that the grip tab of tear strip from label is not covered |
FR2998881B1 (en) * | 2012-12-04 | 2015-02-20 | Arjowiggins Security | OVERLAYING DEVICE AND METHOD FOR IMPLEMENTING THE SAME. |
AU2014230834B9 (en) | 2013-03-14 | 2017-08-31 | Fresenius Kabi Deutschland Gmbh | Injectable morphine formulations |
CA2902346A1 (en) | 2013-03-14 | 2014-09-18 | Becton Dickinson France S.A.S. | Packaging system for oxygen-sensitive drugs |
EP3006367B1 (en) * | 2013-05-27 | 2018-09-19 | Santen Pharmaceutical Co., Ltd | Sealing label with identification function and container wrapped with said sealing label |
DE102014110738A1 (en) | 2014-07-29 | 2016-02-04 | Schreiner Group Gmbh & Co. Kg | Label for a multipart or divisible container |
US10441209B2 (en) | 2016-02-04 | 2019-10-15 | ROCA Medical Ltd. | Antigen regional testing kit |
US11833113B2 (en) | 2021-04-26 | 2023-12-05 | Express Scripts Strategic Development, Inc. | Cap assembly for a medication container |
US20220388720A1 (en) * | 2021-06-07 | 2022-12-08 | 1918497 Ontario Inc. | Container assembly including label |
Citations (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US828770A (en) * | 1901-12-04 | 1906-08-14 | Caffeeno Drug Company | Combined wrapper and label for bottles and boxes. |
US2666542A (en) * | 1948-05-24 | 1954-01-19 | Charles S Price | Adhesive metal foil, bottle cap thereof, and method |
US2954139A (en) * | 1956-12-12 | 1960-09-27 | Celon Company | Tear strip for seals |
US3015429A (en) * | 1959-03-18 | 1962-01-02 | Contadina Foods | Divider package |
US3088830A (en) * | 1959-10-20 | 1963-05-07 | Owens Illinois Glass Co | Hermetically sealed food package with tamper resistant closure |
US3490163A (en) * | 1967-03-01 | 1970-01-20 | Vickers Ltd | Labeled container and method of recording data thereon |
US3733002A (en) * | 1970-10-12 | 1973-05-15 | M Fujio | Sealed container |
US3750317A (en) * | 1971-09-17 | 1973-08-07 | A Morgan | Compound tear label |
US3811591A (en) * | 1971-10-19 | 1974-05-21 | New England Nuclear Corp | Dually sealable, non-leaking vial for shipping radioactive materials |
US3826059A (en) * | 1971-10-19 | 1974-07-30 | New England Nuclear Corp | Method of packaging radioactive materials |
US3951292A (en) * | 1974-10-15 | 1976-04-20 | Owens-Illinois, Inc. | Pilfer-proof neckband for a bottle |
US3983645A (en) * | 1975-01-08 | 1976-10-05 | Becton, Dickinson And Company | Tamper-proof label |
US3984005A (en) * | 1974-10-15 | 1976-10-05 | Owens-Illinois, Inc. | Decorative neckband label for a bottle |
US4312523A (en) * | 1979-10-29 | 1982-01-26 | Paco Packaging Incorporated | Label for container having pharmaceutical product therein |
US4420092A (en) * | 1982-09-01 | 1983-12-13 | Mpl Inc. | Tamper-resistant pharmaceutical vial and cap assembly |
US4540101A (en) * | 1983-10-26 | 1985-09-10 | Aluminum Company Of America | Container assembly including a tamper-indicating band |
US4546881A (en) * | 1983-08-03 | 1985-10-15 | Tasma Gerald W | Tamperproof packaging |
US4633648A (en) * | 1985-05-06 | 1987-01-06 | Minnesota Mining And Manufacturing Company | Container closure seal and method of making |
US4641362A (en) * | 1984-10-25 | 1987-02-03 | C. Muller & Associates, Inc. | Protective dispensing assembly for ultrapure liquids |
US4724973A (en) * | 1987-04-07 | 1988-02-16 | Smithkline Beckman Corporation | Tamper evident container seal |
US4804984A (en) * | 1987-08-20 | 1989-02-14 | W. Haking Enterprises Limited | Packaged camera assembly |
US4813559A (en) * | 1988-03-17 | 1989-03-21 | General Foods Corporation | Tamper-evident container |
US4895266A (en) * | 1988-11-23 | 1990-01-23 | Continental White Cap, Inc. | Tamper indicating band for plastic closure |
US4964513A (en) * | 1990-02-20 | 1990-10-23 | Eastman Kodak Company | Package |
US4976798A (en) * | 1990-01-12 | 1990-12-11 | Shibuya America Corporation | Method of applying a plastic wrap to a contoured container |
US5000804A (en) * | 1987-05-13 | 1991-03-19 | Nugent Edward L | Process for making body fluid sample collection tube composite |
US5048711A (en) * | 1990-06-28 | 1991-09-17 | Sage Products, Inc. | Label indicator for screw thread closure and method of use |
US5205827A (en) * | 1988-12-14 | 1993-04-27 | Patco Ventures Ltd. | Safety syringe needle device with interchangeable and retractable needle platform |
US5230429A (en) * | 1990-12-13 | 1993-07-27 | Etheredge Iii Robert W | Tamper-evident injectable drug vial |
US5292018A (en) * | 1992-07-07 | 1994-03-08 | Travisano Frank P | Tamper evident seal and system |
US5383558A (en) * | 1992-09-11 | 1995-01-24 | Kraft General Foods, Inc. | Sealed container |
US5495944A (en) * | 1993-10-21 | 1996-03-05 | Burroughs Wellcome Co. | Bottle with tamper evident wrapping |
US5544770A (en) * | 1993-05-07 | 1996-08-13 | Travisano; Frank P. | Tamper evident seal and system |
US5601314A (en) * | 1995-10-03 | 1997-02-11 | Moore Business Forms, Inc. | C-folded pharmacy label |
US5605230A (en) * | 1994-10-11 | 1997-02-25 | Elr, Inc. | Sealed label having anti-counterfeit construction |
US5727819A (en) * | 1996-05-31 | 1998-03-17 | Pharmagraphics L.L.C, Midwest | Resealable laminated package label having tamper resistant feature |
US5857579A (en) * | 1990-07-13 | 1999-01-12 | J. G. Finneran Associates | Crimp top seal for vials |
US6146729A (en) * | 1998-04-30 | 2000-11-14 | Nihda; Christopher J. P. | Film seal |
US6226619B1 (en) * | 1998-10-29 | 2001-05-01 | International Business Machines Corporation | Method and system for preventing counterfeiting of high price wholesale and retail items |
US6276725B1 (en) * | 1999-04-09 | 2001-08-21 | The Standard Register Company | Automation friendly security labels for specimen container |
US6385878B1 (en) * | 1999-02-09 | 2002-05-14 | Stephen Key Design, Llc | Rotatable label system including tamper-evident feature and method for constructing same |
US6688465B2 (en) * | 2000-01-24 | 2004-02-10 | Illinois Tool Works Inc. | System and method for packaging oriented containers |
US6692478B1 (en) * | 1998-05-04 | 2004-02-17 | Paradis Joseph R | Swabbable needleless vial access |
US20040060892A1 (en) * | 2002-09-30 | 2004-04-01 | Heston Jeffrey C | Closure having taper-evidencing label |
US6746744B1 (en) * | 1999-08-17 | 2004-06-08 | Santen Pharmaceutical Co., Ltd. | Sealing label |
US6786329B2 (en) * | 2002-03-28 | 2004-09-07 | Meisei Sansho Co., Ltd. | Packaging container and method of making same |
US6908113B2 (en) * | 2001-08-15 | 2005-06-21 | Laboratories Merck Sharp And Dohme-Chibret, Snc | Tamper-evident label |
US6955000B2 (en) * | 2002-10-25 | 2005-10-18 | National Label Company | Labeling apparatus and method of making same |
US20060073140A1 (en) * | 2001-08-03 | 2006-04-06 | The Trustees Of The University Of Pennsylvania | Monoclonal antibodies to activated erbB family members and methods of use thereof |
US7225598B2 (en) * | 2003-07-30 | 2007-06-05 | Paoletti Richard D | Alert medication safety seal system and method |
US20070130811A1 (en) * | 2005-12-09 | 2007-06-14 | U.S. Smokeless Tobacco Company | Tamper evident label |
US20070241075A1 (en) * | 2006-04-14 | 2007-10-18 | Polytop Corporation | Tamper Evident Dispensing Closure and Label System With Improved Label |
US7311205B2 (en) * | 2005-01-25 | 2007-12-25 | Target Brands, Inc. | Pharmacy bottle system including label |
US20080308443A1 (en) * | 2007-06-13 | 2008-12-18 | Baxter International Inc. | Packaging system and method of use |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB158342A (en) | 1919-10-31 | 1921-01-31 | Alfred Dunhill | Improvements in or relating to labels for tin and other boxes and the like |
US4544073A (en) * | 1984-01-30 | 1985-10-01 | Bristol-Myers Company | Bottle-overcap combination |
US4658974A (en) * | 1985-01-07 | 1987-04-21 | Suntory Limited | Transparent liquid container bottle with tinted label and base cup |
JPS63197542U (en) * | 1987-06-12 | 1988-12-20 | ||
US4921277A (en) * | 1988-10-24 | 1990-05-01 | Academy Of Applied Science, Inc. | Method of labeling needle syringes and medication vials and novel labels therefor |
GB2240095A (en) | 1990-01-18 | 1991-07-24 | Robinson & Sons Ltd | Tamper evident package |
US5284263A (en) * | 1990-10-30 | 1994-02-08 | The West Company, Incorporated | Decoration, identification and differentiation closure system |
FR2677336B1 (en) | 1991-06-07 | 1993-10-15 | Bel Fromageries | PACKAGING BOX, PARTICULARLY PACKED PROCESSED CHEESE PORTIONS. |
US5967559A (en) * | 1998-01-09 | 1999-10-19 | Abramowitz; Joseph M. | Rapid visual impact patient identifier and method |
JP2000105536A (en) | 1998-09-28 | 2000-04-11 | Kenji Suzuki | Label with parallel perforated line |
JP3603263B2 (en) | 1999-08-17 | 2004-12-22 | 参天製薬株式会社 | Sealing label |
WO2001094126A1 (en) * | 2000-06-08 | 2001-12-13 | Kaufman Stacy R | Verification of prescription information and warning label |
JP2005075387A (en) | 2003-08-29 | 2005-03-24 | Toppan Printing Co Ltd | Shrink label |
JP4343677B2 (en) | 2003-12-22 | 2009-10-14 | 株式会社岩田レーベル | Shrink label |
ATE444522T1 (en) | 2005-05-25 | 2009-10-15 | Nxp Bv | METHOD FOR STARTING UP A TERMINAL, MEMORY AND TERMINAL THEREFOR |
US20070102316A1 (en) * | 2005-11-08 | 2007-05-10 | Conopco, Inc., D/B/A Unilever | Packaging with continuing labels |
US20080308444A1 (en) * | 2007-06-13 | 2008-12-18 | Baxter International Inc. | Packaging system and method of alerting a practitioner |
-
2007
- 2007-06-13 US US11/762,494 patent/US20080308444A1/en not_active Abandoned
- 2007-07-23 MX MX2007014336A patent/MX2007014336A/en active IP Right Grant
- 2007-07-23 WO PCT/US2007/074117 patent/WO2008153581A1/en active Application Filing
- 2007-09-24 DE DE602007007591T patent/DE602007007591D1/en active Active
- 2007-09-24 EP EP07253775A patent/EP2003064B1/en active Active
- 2007-09-24 ES ES07253775T patent/ES2348628T3/en active Active
- 2007-09-24 PT PT07253775T patent/PT2003064E/en unknown
- 2007-09-24 PL PL07253775T patent/PL2003064T3/en unknown
- 2007-09-24 AT AT07253775T patent/ATE473175T1/en active
- 2007-10-17 JP JP2007270715A patent/JP2008307361A/en not_active Withdrawn
-
2010
- 2010-08-30 US US12/871,101 patent/US9463138B2/en active Active
-
2013
- 2013-08-19 US US13/970,194 patent/US20130334165A1/en not_active Abandoned
-
2015
- 2015-01-07 US US14/591,512 patent/US10702452B2/en active Active
-
2020
- 2020-01-24 US US16/751,958 patent/US20200163832A1/en not_active Abandoned
- 2020-01-24 US US16/752,033 patent/US20200163833A1/en not_active Abandoned
Patent Citations (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US828770A (en) * | 1901-12-04 | 1906-08-14 | Caffeeno Drug Company | Combined wrapper and label for bottles and boxes. |
US2666542A (en) * | 1948-05-24 | 1954-01-19 | Charles S Price | Adhesive metal foil, bottle cap thereof, and method |
US2954139A (en) * | 1956-12-12 | 1960-09-27 | Celon Company | Tear strip for seals |
US3015429A (en) * | 1959-03-18 | 1962-01-02 | Contadina Foods | Divider package |
US3088830A (en) * | 1959-10-20 | 1963-05-07 | Owens Illinois Glass Co | Hermetically sealed food package with tamper resistant closure |
US3490163A (en) * | 1967-03-01 | 1970-01-20 | Vickers Ltd | Labeled container and method of recording data thereon |
US3733002A (en) * | 1970-10-12 | 1973-05-15 | M Fujio | Sealed container |
US3750317A (en) * | 1971-09-17 | 1973-08-07 | A Morgan | Compound tear label |
US3811591A (en) * | 1971-10-19 | 1974-05-21 | New England Nuclear Corp | Dually sealable, non-leaking vial for shipping radioactive materials |
US3826059A (en) * | 1971-10-19 | 1974-07-30 | New England Nuclear Corp | Method of packaging radioactive materials |
US3984005A (en) * | 1974-10-15 | 1976-10-05 | Owens-Illinois, Inc. | Decorative neckband label for a bottle |
US3951292A (en) * | 1974-10-15 | 1976-04-20 | Owens-Illinois, Inc. | Pilfer-proof neckband for a bottle |
US3983645A (en) * | 1975-01-08 | 1976-10-05 | Becton, Dickinson And Company | Tamper-proof label |
US4312523A (en) * | 1979-10-29 | 1982-01-26 | Paco Packaging Incorporated | Label for container having pharmaceutical product therein |
US4420092A (en) * | 1982-09-01 | 1983-12-13 | Mpl Inc. | Tamper-resistant pharmaceutical vial and cap assembly |
US4546881A (en) * | 1983-08-03 | 1985-10-15 | Tasma Gerald W | Tamperproof packaging |
US4540101A (en) * | 1983-10-26 | 1985-09-10 | Aluminum Company Of America | Container assembly including a tamper-indicating band |
US4641362A (en) * | 1984-10-25 | 1987-02-03 | C. Muller & Associates, Inc. | Protective dispensing assembly for ultrapure liquids |
US4633648A (en) * | 1985-05-06 | 1987-01-06 | Minnesota Mining And Manufacturing Company | Container closure seal and method of making |
US4724973A (en) * | 1987-04-07 | 1988-02-16 | Smithkline Beckman Corporation | Tamper evident container seal |
US5000804A (en) * | 1987-05-13 | 1991-03-19 | Nugent Edward L | Process for making body fluid sample collection tube composite |
US4804984A (en) * | 1987-08-20 | 1989-02-14 | W. Haking Enterprises Limited | Packaged camera assembly |
US4813559A (en) * | 1988-03-17 | 1989-03-21 | General Foods Corporation | Tamper-evident container |
US4895266A (en) * | 1988-11-23 | 1990-01-23 | Continental White Cap, Inc. | Tamper indicating band for plastic closure |
US5205827A (en) * | 1988-12-14 | 1993-04-27 | Patco Ventures Ltd. | Safety syringe needle device with interchangeable and retractable needle platform |
US4976798A (en) * | 1990-01-12 | 1990-12-11 | Shibuya America Corporation | Method of applying a plastic wrap to a contoured container |
US4964513A (en) * | 1990-02-20 | 1990-10-23 | Eastman Kodak Company | Package |
US5048711A (en) * | 1990-06-28 | 1991-09-17 | Sage Products, Inc. | Label indicator for screw thread closure and method of use |
US5857579A (en) * | 1990-07-13 | 1999-01-12 | J. G. Finneran Associates | Crimp top seal for vials |
US5230429A (en) * | 1990-12-13 | 1993-07-27 | Etheredge Iii Robert W | Tamper-evident injectable drug vial |
US5292018A (en) * | 1992-07-07 | 1994-03-08 | Travisano Frank P | Tamper evident seal and system |
US5383558A (en) * | 1992-09-11 | 1995-01-24 | Kraft General Foods, Inc. | Sealed container |
US5931323A (en) * | 1992-09-11 | 1999-08-03 | Kraft Foods, Inc. | Sealed container |
US5544770A (en) * | 1993-05-07 | 1996-08-13 | Travisano; Frank P. | Tamper evident seal and system |
US5495944A (en) * | 1993-10-21 | 1996-03-05 | Burroughs Wellcome Co. | Bottle with tamper evident wrapping |
US5605230A (en) * | 1994-10-11 | 1997-02-25 | Elr, Inc. | Sealed label having anti-counterfeit construction |
US5601314A (en) * | 1995-10-03 | 1997-02-11 | Moore Business Forms, Inc. | C-folded pharmacy label |
US5727819A (en) * | 1996-05-31 | 1998-03-17 | Pharmagraphics L.L.C, Midwest | Resealable laminated package label having tamper resistant feature |
US6146729A (en) * | 1998-04-30 | 2000-11-14 | Nihda; Christopher J. P. | Film seal |
US6692478B1 (en) * | 1998-05-04 | 2004-02-17 | Paradis Joseph R | Swabbable needleless vial access |
US6226619B1 (en) * | 1998-10-29 | 2001-05-01 | International Business Machines Corporation | Method and system for preventing counterfeiting of high price wholesale and retail items |
US6385878B1 (en) * | 1999-02-09 | 2002-05-14 | Stephen Key Design, Llc | Rotatable label system including tamper-evident feature and method for constructing same |
US6276725B1 (en) * | 1999-04-09 | 2001-08-21 | The Standard Register Company | Automation friendly security labels for specimen container |
US6746744B1 (en) * | 1999-08-17 | 2004-06-08 | Santen Pharmaceutical Co., Ltd. | Sealing label |
US6688465B2 (en) * | 2000-01-24 | 2004-02-10 | Illinois Tool Works Inc. | System and method for packaging oriented containers |
US20060073140A1 (en) * | 2001-08-03 | 2006-04-06 | The Trustees Of The University Of Pennsylvania | Monoclonal antibodies to activated erbB family members and methods of use thereof |
US6908113B2 (en) * | 2001-08-15 | 2005-06-21 | Laboratories Merck Sharp And Dohme-Chibret, Snc | Tamper-evident label |
US6786329B2 (en) * | 2002-03-28 | 2004-09-07 | Meisei Sansho Co., Ltd. | Packaging container and method of making same |
US20040060892A1 (en) * | 2002-09-30 | 2004-04-01 | Heston Jeffrey C | Closure having taper-evidencing label |
US6955000B2 (en) * | 2002-10-25 | 2005-10-18 | National Label Company | Labeling apparatus and method of making same |
US7225598B2 (en) * | 2003-07-30 | 2007-06-05 | Paoletti Richard D | Alert medication safety seal system and method |
US7311205B2 (en) * | 2005-01-25 | 2007-12-25 | Target Brands, Inc. | Pharmacy bottle system including label |
US20070130811A1 (en) * | 2005-12-09 | 2007-06-14 | U.S. Smokeless Tobacco Company | Tamper evident label |
US20070241075A1 (en) * | 2006-04-14 | 2007-10-18 | Polytop Corporation | Tamper Evident Dispensing Closure and Label System With Improved Label |
US20080308443A1 (en) * | 2007-06-13 | 2008-12-18 | Baxter International Inc. | Packaging system and method of use |
Cited By (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9463138B2 (en) | 2007-06-13 | 2016-10-11 | Baxter International Inc. | Packaging system |
US20100326868A1 (en) * | 2007-06-13 | 2010-12-30 | Baxter International Inc. | Packaging System |
US20080308443A1 (en) * | 2007-06-13 | 2008-12-18 | Baxter International Inc. | Packaging system and method of use |
US10702452B2 (en) | 2007-06-13 | 2020-07-07 | Baxter International Inc. | Packaging system and methods of alerting a practitioner |
US11707408B2 (en) | 2011-10-25 | 2023-07-25 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US10413481B2 (en) | 2011-10-25 | 2019-09-17 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9241869B2 (en) | 2011-10-25 | 2016-01-26 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US11707410B2 (en) | 2011-10-25 | 2023-07-25 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US20130202823A1 (en) * | 2011-10-25 | 2013-08-08 | Wendell P. Weeks | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9186295B2 (en) | 2011-10-25 | 2015-11-17 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9474689B2 (en) | 2011-10-25 | 2016-10-25 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9474688B2 (en) | 2011-10-25 | 2016-10-25 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US10350139B2 (en) | 2011-10-25 | 2019-07-16 | Corning Incorporated | Pharmaceutical glass packaging assuring pharmaceutical sterility |
US9198829B2 (en) | 2011-10-25 | 2015-12-01 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US10413483B2 (en) | 2011-10-25 | 2019-09-17 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US10413482B2 (en) | 2011-10-25 | 2019-09-17 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US11707409B2 (en) * | 2011-10-25 | 2023-07-25 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US10441505B2 (en) | 2011-10-25 | 2019-10-15 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US11124328B2 (en) | 2012-06-07 | 2021-09-21 | Corning Incorporated | Delamination resistant glass containers |
US10273048B2 (en) | 2012-06-07 | 2019-04-30 | Corning Incorporated | Delamination resistant glass containers with heat-tolerant coatings |
US9988174B2 (en) | 2012-06-07 | 2018-06-05 | Corning Incorporated | Delamination resistant glass containers |
US10787292B2 (en) | 2012-06-28 | 2020-09-29 | Corning Incorporated | Delamination resistant glass containers with heat-tolerant coatings |
US11608290B2 (en) | 2012-06-28 | 2023-03-21 | Corning Incorporated | Delamination resistant glass containers with heat-tolerant coatings |
US10273049B2 (en) | 2012-06-28 | 2019-04-30 | Corning Incorporated | Delamination resistant glass containers with heat-tolerant coatings |
US9428302B2 (en) | 2012-06-28 | 2016-08-30 | Corning Incorporated | Delamination resistant glass containers with heat-tolerant coatings |
US10023495B2 (en) | 2012-11-30 | 2018-07-17 | Corning Incorporated | Glass containers with improved strength and improved damage tolerance |
US10117806B2 (en) | 2012-11-30 | 2018-11-06 | Corning Incorporated | Strengthened glass containers resistant to delamination and damage |
US10813835B2 (en) | 2012-11-30 | 2020-10-27 | Corning Incorporated | Glass containers with improved strength and improved damage tolerance |
US10786431B2 (en) | 2012-11-30 | 2020-09-29 | Corning Incorporated | Glass containers with delamination resistance and improved damage tolerance |
US10307333B2 (en) | 2012-11-30 | 2019-06-04 | Corning Incorporated | Glass containers with delamination resistance and improved damage tolerance |
US10307334B2 (en) | 2012-11-30 | 2019-06-04 | Corning Incorporated | Glass containers with delamination resistance and improved damage tolerance |
US10507164B2 (en) | 2012-11-30 | 2019-12-17 | Corning Incorporated | Glass containers with improved strength and improved damage tolerance |
US9717648B2 (en) | 2013-04-24 | 2017-08-01 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9700485B2 (en) | 2013-04-24 | 2017-07-11 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9713572B2 (en) | 2013-04-24 | 2017-07-25 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9707154B2 (en) | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9839579B2 (en) | 2013-04-24 | 2017-12-12 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9707153B2 (en) | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9849066B2 (en) | 2013-04-24 | 2017-12-26 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9707155B2 (en) | 2013-04-24 | 2017-07-18 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9603775B2 (en) | 2013-04-24 | 2017-03-28 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9717649B2 (en) | 2013-04-24 | 2017-08-01 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US9700486B2 (en) | 2013-04-24 | 2017-07-11 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
US20160167871A1 (en) * | 2013-12-12 | 2016-06-16 | ASCLEMED USA, INC. dba EnovaChem Manufacturing | Vitamin b-12 injection kit |
US20150166255A1 (en) * | 2013-12-12 | 2015-06-18 | ASCLEMED USA, INC. dba EnovaChem Manufacturing | Vitamin b-12 injection kit |
US10899659B2 (en) | 2014-09-05 | 2021-01-26 | Corning Incorporated | Glass articles and methods for improving the reliability of glass articles |
US10065884B2 (en) | 2014-11-26 | 2018-09-04 | Corning Incorporated | Methods for producing strengthened and durable glass containers |
US11951072B2 (en) | 2019-10-15 | 2024-04-09 | Corning Incorporated | Glass containers with improved strength and improved damage tolerance |
EP4085891A1 (en) * | 2021-05-05 | 2022-11-09 | B. Braun Melsungen AG | Dexmedetomidine-solution in a low-density polyethylene container |
WO2022233837A1 (en) * | 2021-05-05 | 2022-11-10 | B. Braun Melsungen Ag | Dexmedetomidine-solution in a low-density polyethylene container |
Also Published As
Publication number | Publication date |
---|---|
EP2003064B1 (en) | 2010-07-07 |
PT2003064E (en) | 2010-10-07 |
WO2008153581A1 (en) | 2008-12-18 |
US10702452B2 (en) | 2020-07-07 |
PL2003064T3 (en) | 2010-12-31 |
US20150144586A1 (en) | 2015-05-28 |
US20200163832A1 (en) | 2020-05-28 |
US20130334165A1 (en) | 2013-12-19 |
US20100326868A1 (en) | 2010-12-30 |
US20200163833A1 (en) | 2020-05-28 |
EP2003064A1 (en) | 2008-12-17 |
ES2348628T3 (en) | 2010-12-09 |
ATE473175T1 (en) | 2010-07-15 |
JP2008307361A (en) | 2008-12-25 |
DE602007007591D1 (en) | 2010-08-19 |
US9463138B2 (en) | 2016-10-11 |
MX2007014336A (en) | 2009-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200163832A1 (en) | Packaging system and methods of alerting practitioner | |
US20080308443A1 (en) | Packaging system and method of use | |
EP1456092B1 (en) | Container, particularly a bottle containing beverages | |
CH657341A5 (en) | PUNCHABLE CLOSURE SECTION ON A GLASS BOTTLE. | |
JP2014518822A (en) | Closing device and container having the device | |
EP0883554B1 (en) | A security closure with a piercable portion for containers | |
EP1451081B1 (en) | Sealable beverage bottle | |
CA2602044C (en) | Packaging system and method of alerting a practitioner | |
CA2602593C (en) | Packaging system and method of use | |
ES2761354T3 (en) | Closing system for bottles containing lyophilized or liquid products, in particular pharmaceutical products for injection or infusion | |
WO2012062444A1 (en) | Blister packaging for liquid | |
EP2121473A2 (en) | Packaging for small bottles | |
US9622940B2 (en) | Medicine packaging PTP sheet | |
GB2492586A (en) | Double Tamper Evident Seal | |
US20220081176A1 (en) | Labelling arrangement for a multi-part container, system and method for applying a labelling arrangement to a multi-part container | |
EP0699592A2 (en) | Tear-open cap for bottle-like container | |
WO2006008261A1 (en) | Container for pharmaceutical products | |
US4553683A (en) | Tamper resistant closures | |
CN217886564U (en) | Penicillin bottle | |
EP3738900A1 (en) | Container, especially for medicines | |
US20240067412A1 (en) | Plastic closure device for a container for parenteral pharmaceutical products | |
WO2004022445A1 (en) | Security carrier | |
JP2006176204A (en) | Cap for pet bottle | |
KR20170134143A (en) | Structure of Outlet within Inner-Side of Bottle Neck | |
ITMI990060U1 (en) | PROTECTIVE DEVICE FOR CAN WITH OPENING SYSTEMS THAT CANNOT BE SEPARATED FROM THE SAME CAN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BAXTER INTERNATIONAL INC., ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MCCLAIN, KIMBERLY A;BAKLYCKI, MICHAEL;MCDEVITT, THOMAS D;REEL/FRAME:019547/0908 Effective date: 20070626 Owner name: BAXTER HEALTHCARE S.A., SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MCCLAIN, KIMBERLY A;BAKLYCKI, MICHAEL;MCDEVITT, THOMAS D;REEL/FRAME:019547/0908 Effective date: 20070626 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |